Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Xevolac

Approved

STANDARD

Xevolac

PT Novell Pharmaceutical Laboratories🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: f1c68fef7089ee01
Company: PT Novell Pharmaceutical Laboratories
Type: Standard

Approval Details

Approval Id: f1c68fef7089ee01
Drug Approval Philippines Name: Xevolac
Product Name: Xevolac
Registration Number: DR-XY36935
Brand Name: Xevolac
Generic Name: Ketoralac Trometamol
Dosage Form: Solution For Injection (IM/IV)
Dosage Strength: 30mg/mL
Manufacturer: PT Novell Pharmaceutical Laboratories
Company Detail Path: /organization/pt-novell-pharmaceutical-laboratories
Issuance Date: 15 November 2022
Expiry Date: 06 November 2026
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

f1c68fef7089ee01

Type

Standard

Back to Philippines FDA Approvals

Xevolac - Philippines FDA Drug Approval Details